Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI France ETF (EWQ) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance

iShares MSCI France ETFTrade
GE HealthCare Technologies Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI France ETF vs GE HealthCare Technologies Inc. Common Stock — how do they compare? iShares MSCI France ETF trades at $41.52 (market cap $332.79M), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 92.9× iShares MSCI France ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares MSCI France ETF pays none. Which is the better fit depends on your goals.

EWQGEHC
Market Cap
$332.79M$30.93B
Volume
668,9205,033,451
Sector
Broad Market / FactorHealth
52-Week High
$48.35$88.16
52-Week Low
$41.24$59.48
Typical Hold Time
57 Days—
Enterprise Value
—$39.39B
Dividend Yield
—0.23%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI France ETF

EWQ is trading at $41.63, up 0.95% with a bearish technical signal from moving averages. The stock faces European market pressures including ECB rate hikes and energy-driven inflation concerns. Key support sits at $41 with resistance at $42, while RSI indicators show mixed signals between neutral and oversold conditions.

European economic uncertainty and monetary tightening create headwinds, though Goldman Sachs notes resilience in European equities. The stock's technical weakness suggests cautious near-term positioning amid macroeconomic volatility in eurozone markets.

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Returns comparison

Trailing returns across standard periods

About iShares MSCI France ETF

EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.

Read more on EWQ →

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →